Metformin-associated lactic acidosis and factors associated with 30-day mortality
- PMID: 36040976
- PMCID: PMC9426915
- DOI: 10.1371/journal.pone.0273678
Metformin-associated lactic acidosis and factors associated with 30-day mortality
Abstract
Background: Metformin-associated lactic acidosis (MALA) is a rare event but underrecognition may lead to unfavorable outcomes in type 2 diabetes patients. While many risk factors of MALA have been identified, how to reduce mortality from MALA is a matter of debate. This study aimed to explore the factors associated with 30-day mortality amongst MALA patients.
Methods: An observational study enrolled patients diagnosed with MALA between January 2014 and December 2017. MALA was defined by a history of metformin administration, metabolic acidosis (arterial blood gas pH <7.35 or HCO3 <15 mmol/L), and elevated plasma lactate level (>5 mmol/L). We examined risk factors including age, sex, underlying diseases, current medications, blood tests, disease severity, and dialysis data. Mortality status was identified from medical records or report on telephone.
Results: We included 105 MALA patients. Most patients (95.2%) were diagnosed acute kidney injury stage 3 according to KDIGO 2012 definition. The 30-day mortality rate was 36.2% and dialysis rate was 85.7%. The survivors had higher proportions of underlying chronic kidney disease, presence of metabolic acidosis, receiving renal replacement therapy within 6 hours, and haemodialysis, whereas the non-survivors had higher percentage of hypertension and disease severity. Lower APACHE II score (HR = 0.95; 95%CI, 0.91-0.99; p = 0.038), time to dialysis < 6 hours (0.31; 0.14-0.69; 0.004), and haemodialysis (0.20;0.06-0.67; 0.010) were associated with lower 30-day mortality, using multivariate Cox-regression analysis.
Conclusions: Mortality rate amongst patients with MALA was high. Early dialysis treatment within 6 hours after admission and haemodialysis were independently associated with lower 30-day mortality. The large scale, well-designed studies need to confirm these encouraging results.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.J Clin Pharm Ther. 2011 Jun;36(3):376-82. doi: 10.1111/j.1365-2710.2010.01192.x. Epub 2010 Aug 25. J Clin Pharm Ther. 2011. PMID: 21545617
-
Metformin associated lactic acidosis (MALA): clinical profiling and management.J Nephrol. 2016 Dec;29(6):783-789. doi: 10.1007/s40620-016-0267-8. Epub 2016 Jan 22. J Nephrol. 2016. PMID: 26800971 Review.
-
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up.BMC Nephrol. 2018 Apr 2;19(1):77. doi: 10.1186/s12882-018-0875-8. BMC Nephrol. 2018. PMID: 29609531 Free PMC article.
-
Identifying patients with metformin associated lactic acidosis in the emergency department.Int J Clin Pharm. 2020 Oct;42(5):1286-1292. doi: 10.1007/s11096-020-01069-2. Epub 2020 Sep 22. Int J Clin Pharm. 2020. PMID: 32960426 Free PMC article.
-
Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA.J Med Toxicol. 2020 Apr;16(2):222-229. doi: 10.1007/s13181-019-00755-6. Epub 2020 Jan 6. J Med Toxicol. 2020. PMID: 31907741 Free PMC article.
Cited by
-
Veno-Arterial Extracorporeal Membrane Oxygenation for Treating Refractory Shock in Severe Metformin-Associated Lactic Acidosis: A Case Report.Cureus. 2025 Mar 25;17(3):e81197. doi: 10.7759/cureus.81197. eCollection 2025 Mar. Cureus. 2025. PMID: 40291305 Free PMC article.
-
An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021.Hosp Pharm. 2024 Aug;59(4):465-470. doi: 10.1177/00185787241230628. Epub 2024 Feb 9. Hosp Pharm. 2024. PMID: 38919762 Free PMC article.
-
Severe Metformin-Associated Lactic Acidosis Managed Without Dialysis in an Elderly Patient With Multiple Comorbidities: A Case Report.Cureus. 2025 Aug 9;17(8):e89686. doi: 10.7759/cureus.89686. eCollection 2025 Aug. Cureus. 2025. PMID: 40787182 Free PMC article.
-
Metformin-Associated Lactic Acidosis During Docetaxel Therapy for Castration-Resistant Prostate Cancer: A Case Report.IJU Case Rep. 2025 Jun 16;8(4):411-414. doi: 10.1002/iju5.70055. eCollection 2025 Jul. IJU Case Rep. 2025. PMID: 40607458 Free PMC article.
-
Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model.Pharmaceuticals (Basel). 2024 Oct 14;17(10):1369. doi: 10.3390/ph17101369. Pharmaceuticals (Basel). 2024. PMID: 39459008 Free PMC article.
References
-
- Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, et al.. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157(9):601–10. doi: 10.7326/0003-4819-157-9-201211060-00003 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical